S. Cannistra, Cancer of the Ovary, New England Journal of Medicine, vol.351, issue.24, pp.2519-2529, 2004.
DOI : 10.1056/NEJMra041842

B. Tretarre, L. Remontet, F. Menegoz, J. Mace-lesec-'h, P. Grosclaude et al., Les cancers de l???ovaire : incidence et mortalit?? en France, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.34, issue.2, pp.154-161, 2005.
DOI : 10.1016/S0368-2315(05)82707-3

J. Pfisterer and J. Ledermann, Management of Platinum-Sensitive Recurrent Ovarian Cancer, Seminars in Oncology, vol.33, pp.12-16, 2006.
DOI : 10.1053/j.seminoncol.2006.03.012

W. Ceelen and M. Bracke, Peritoneal minimal residual disease in colorectal cancer: mechanisms, prevention, and treatment, The Lancet Oncology, vol.10, issue.1, pp.72-79, 2009.
DOI : 10.1016/S1470-2045(08)70335-8

L. Bourguignon, E. Gilad, and K. Peyrollier, Heregulin-mediated ErbB2-ERK Signaling Activates Hyaluronan Synthases Leading to CD44-dependent Ovarian Tumor Cell Growth and Migration, Journal of Biological Chemistry, vol.282, issue.27, pp.19426-19441, 2007.
DOI : 10.1074/jbc.M610054200

R. Lis, C. Touboul, C. Raynaud, J. Malek, K. Suhre et al., Mesenchymal Cell Interaction with Ovarian Cancer Cells Triggers Pro-Metastatic Properties, PLoS ONE, vol.474, issue.5, p.38340, 2012.
DOI : 10.1371/journal.pone.0038340.s002

A. Rafii, P. Mirshahi, M. Poupot, A. Faussat, A. Simon et al., Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours, PLoS ONE, vol.171, issue.2, p.3894, 2008.
DOI : 10.1371/journal.pone.0003894.s002

K. Yamada and E. Cukierman, Modeling Tissue Morphogenesis and Cancer in 3D, Cell, vol.130, issue.4, pp.601-610, 2007.
DOI : 10.1016/j.cell.2007.08.006

R. Freedman, M. Deavers, J. Liu, and E. Wang, Peritoneal inflammation -A microenvironment for Epithelial Ovarian Cancer (EOC), Journal of Translational Medicine, vol.2, issue.1, p.23, 2004.
DOI : 10.1186/1479-5876-2-23

S. Ilancheran, Y. Moodley, and U. Manuelpillai, Human Fetal Membranes: A Source of Stem Cells for Tissue Regeneration and Repair?, Placenta, vol.30, issue.1, pp.2-10, 2009.
DOI : 10.1016/j.placenta.2008.09.009

P. Van-der-linden, A. De-goeij, G. Dunselman, H. Erkens, and J. Evers, Endometrial cell adhesion in an in vitro model using intact amniotic membranes**Supported in part by research grants from Ipsen Biotech, Paris, France and from Organon International B.V., Oss, The Netherlands., Fertility and Sterility, vol.65, issue.1, pp.76-80, 1996.
DOI : 10.1016/S0015-0282(16)58030-3

P. Groothuis, C. Koks, A. De-goeij, G. Dunselman, J. Arends et al., Adhesion of human endometrium to the epithelial lining and extracellular matrix of amnion in vitro: an electron microscopic study, Human Reproduction, vol.13, issue.8, pp.2275-2281, 1998.
DOI : 10.1093/humrep/13.8.2275

C. Raynaud, M. Maleki, R. Lis, B. Ahmed, I. Al-azwani et al., Comprehensive Characterization of Mesenchymal Stem Cells from Human Placenta and Fetal Membrane and Their Response to Osteoactivin Stimulation, Stem Cells International, vol.238, issue.5, p.658356, 2012.
DOI : 10.1006/bbrc.1995.1712

K. Charles, H. Kulbe, R. Soper, M. Escorcio-correia, T. Lawrence et al., The tumor-promoting actions of TNF-?? involve TNFR1 and IL-17 in ovarian cancer in mice and humans, Journal of Clinical Investigation, vol.119, issue.10, pp.3011-3023, 2009.
DOI : 10.1172/JCI39065DS1
URL : https://hal.archives-ouvertes.fr/hal-00499385

H. Kenny, S. Kaur, L. Coussens, and E. Lengyel, The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin, Journal of Clinical Investigation, vol.118, issue.4, pp.1367-1379, 2008.
DOI : 10.1172/JCI33775

H. Kenny, K. Nieman, A. Mitra, and E. Lengyel, The First Line of Intra-abdominal Metastatic Attack: Breaching the Mesothelial Cell Layer, Cancer Discovery, vol.1, issue.2, pp.100-102, 2011.
DOI : 10.1158/2159-8290.CD-11-0117

M. Iwanicki, R. Davidowitz, M. Ng, A. Besser, T. Muranem et al., Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium, Cancer Discovery, vol.1, issue.2, pp.144-147, 2011.
DOI : 10.1158/2159-8274.CD-11-0010

S. Coffelt, F. Marini, K. Watson, K. Zwezdaryk, J. Dembinski et al., The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells, Proceedings of the National Academy of Sciences, vol.106, issue.10, pp.3806-3811, 2009.
DOI : 10.1073/pnas.0900244106

E. Jeon, H. Moon, M. Lee, H. Song, Y. Kim et al., Cancer-Derived Lysophosphatidic Acid Stimulates Differentiation of Human Mesenchymal Stem Cells to Myofibroblast-Like Cells, Stem Cells, vol.25, issue.Pt 3, pp.789-797, 2008.
DOI : 10.1634/stemcells.2007-0742

J. Seo, K. Jeong, W. Oh, H. Sul, J. Sohn et al., Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: Their inhibition by curcumin, Cancer Letters, vol.288, issue.1, pp.50-56, 2010.
DOI : 10.1016/j.canlet.2009.06.023

S. Kidd, E. Spaeth, K. Watson, J. Burks, H. Lu et al., Origins of the Tumor Microenvironment: Quantitative Assessment of Adipose-Derived and Bone Marrow???Derived Stroma, PLoS ONE, vol.21, issue.2, p.30563, 2012.
DOI : 10.1371/journal.pone.0030563.s004

E. Spaeth, J. Dembinski, A. Sasser, K. Watson, A. Klopp et al., Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression, PLoS ONE, vol.72, issue.4, p.4992, 2009.
DOI : 10.1371/journal.pone.0004992.s004

M. Pasquet, M. Golzio, E. Mery, A. Rafii, N. Benabbou et al., Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis, International Journal of Cancer, vol.16, pp.2090-2101, 2010.
DOI : 10.1002/ijc.24886

K. Mclean, Y. Gong, Y. Choi, N. Deng, K. Yang et al., Human ovarian carcinoma???associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production, Journal of Clinical Investigation, vol.121, issue.8, pp.3206-3219, 2011.
DOI : 10.1172/JCI45273DS1

J. Chen, Y. Yao, C. Gong, F. Yu, S. Su et al., CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3, Cancer Cell, vol.19, issue.4, pp.541-555, 2011.
DOI : 10.1016/j.ccr.2011.02.006
URL : http://doi.org/10.1016/j.ccr.2011.02.006

S. Valastyan and R. Weinberg, Tumor Metastasis: Molecular Insights and Evolving Paradigms, Cell, vol.147, issue.2, pp.275-292, 2011.
DOI : 10.1016/j.cell.2011.09.024
URL : http://doi.org/10.1016/j.cell.2011.09.024

K. Rath, H. Funk, M. Bowling, W. Richards, and A. Drew, Expression of soluble interleukin-6 receptor in malignant ovarian tissue, American Journal of Obstetrics and Gynecology, vol.203, issue.3, pp.230-231, 2010.
DOI : 10.1016/j.ajog.2010.03.034

P. Giridhar, H. Funk, C. Gallo, A. Porollo, C. Mercer et al., Interleukin-6 receptor enhances early colonization of the murine omentum by upregulation of a mannose family receptor, LY75, in ovarian tumor cells, Clinical & Experimental Metastasis, vol.68, issue.18, pp.887-897, 2011.
DOI : 10.1007/s10585-011-9420-x

D. Hong, L. Angelo, and R. Kurzrock, Interleukin-6 and its receptor in cancer, Cancer, vol.15, issue.9, pp.1911-1928, 2007.
DOI : 10.1002/cncr.22999

T. Taga, M. Hibi, Y. Hirata, K. Yamasaki, K. Yasukawa et al., Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130, Cell, vol.58, issue.3, pp.573-581, 1989.
DOI : 10.1016/0092-8674(89)90438-8

N. Stahl, T. Farruggella, T. Boulton, Z. Zhong, J. Darnell et al., Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors, Science, vol.267, issue.5202, pp.1349-1353, 1995.
DOI : 10.1126/science.7871433

Y. Yamanaka, K. Nakajima, T. Fukada, M. Hibi, and T. Hirano, Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation, EMBO J, vol.15, pp.1557-1565, 1996.

U. Wegenka, J. Buschmann, C. Lutticken, P. Heinrich, and F. Horn, Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level., Molecular and Cellular Biology, vol.13, issue.1, pp.276-288, 1993.
DOI : 10.1128/MCB.13.1.276

S. Kidd, E. Spaeth, J. Dembinski, M. Dietrich, K. Watson et al., Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging, Stem Cells, vol.116, issue.10, pp.2614-2623, 2009.
DOI : 10.1002/stem.187

M. Colomiere, A. Ward, C. Riley, M. Trenerry, D. Cameron-smith et al., Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial???mesenchymal transition in ovarian carcinomas, British Journal of Cancer, vol.131, issue.5, pp.134-144, 2009.
DOI : 10.1242/jcs.005298

C. Scheel, E. Eaton, S. Li, C. Chaffer, F. Reinhardt et al., Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast, Cell, vol.145, issue.6, pp.926-940, 2011.
DOI : 10.1016/j.cell.2011.04.029

S. Liu, C. Ginestier, S. Ou, S. Clouthier, S. Patel et al., Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks, Cancer Research, vol.71, issue.2, pp.614-624, 2011.
DOI : 10.1158/0008-5472.CAN-10-0538
URL : https://hal.archives-ouvertes.fr/hal-01431944